The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats

The standardized extract of Ginkgo biloba (EGb 761) has been widely employed for its significant benefit in neurodegenerative disorders. Although antioxidative actions have been attributed to this extract, the mechanisms of the multiple principles involved in this pharmacological activity are not completely established. Parkinson's and Alzheimer's diseases are frequently associated with oxidative stress and defects in the cellular protective mechanisms. In this study, the lipid peroxidation (LPO) and the activity of the antioxidant enzymes, catalase (CAT) and superoxide dismutase (SOD) were evaluated in the hippocampus, striatum and substantia nigra (SN) of rats treated with EGb 761. An increase in the CAT and SOD activities in the hippocampus, striatum and SN, and a decrease of the LPO in the hippocampus were observed. These data are additional to the antioxidant properties of EGb 761 reported in the literature and indicate a possible role for the extract in the treatment of diseases involving free radicals and oxidative damage. Copyright © 2001 John Wiley & Sons, Ltd.

[1]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[2]  Y. Oyama,et al.  Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide , 1996, Brain Research.

[3]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[4]  J. O'Brien,et al.  Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease , 1996, Psychological Medicine.

[5]  C. Masters,et al.  Reactive oxygen species and Alzheimer's disease. , 1997, Biochemical pharmacology.

[6]  L. Packer,et al.  Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. , 1995, Biochemical pharmacology.

[7]  M. Beal,et al.  Bioenergetic and oxidative stress in neurodegenerative diseases. , 1995, Life sciences.

[8]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[9]  R. Anton,et al.  Comparative Antilipoperoxidant, Antinecrotic and Scavanging Properties of Terpenes and Biflavones from Ginkgo and some Flavonoids , 1995, Planta medica.

[10]  P. Jenner,et al.  Oxidative stress in Parkinson's disease and other neurodegenerative disorders. , 1996, Pathologie-biologie.

[11]  I. Fridovich,et al.  Superoxide dismutases. , 1975, Annual review of biochemistry.

[12]  C. Marsden,et al.  Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.

[13]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[14]  I W SIZER,et al.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. , 1952, The Journal of biological chemistry.

[15]  Y. Rong,et al.  Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. , 1996, Free radical biology & medicine.